Goserelin
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | DRUG-GOSERELIN |
|---|---|
| Type | Drug |
| Aliases | ZoladexГозерелін |
| Status | pending_clinical_signoff |
| Diseases | None declared |
| Sources | SRC-ESMO-PROSTATE-2024 SRC-NCCN-PROSTATE-2025 |
Drug Facts
| Class | GnRH agonist (LHRH agonist) |
|---|---|
| Mechanism | GnRH receptor agonist with the same flare-then-suppression mechanism as leuprolide; subcutaneous depot implant preferred at sites where IM injections are inconvenient. |
| Ukraine registered | True |
| NSZU reimbursed | True |
| Ukraine last verified | 2026-04-27 |
Notes
Equivalent efficacy to leuprolide; choice often institutional or based on injection logistics.
Used By
No reverse references found in the YAML corpus.